Midlife Cognitive Training Works. Menopause May Matter.

Cognitive training helps in midlife. Menopause-specific claims do not yet.

If you are in midlife and want to protect attention, working memory, or planning skills, structured cognitive training has credible evidence behind it. A 2025 systematic review and meta-analysis of 19 randomized controlled trials in healthy adults aged 40 to 65 found an executive-function benefit of SMD 0.48, along with gains in verbal and working memory. That is a small-to-moderate average effect, not a promise of a new brain by Tuesday. Still, it is large enough to take seriously.

The more intriguing question is whether the menopausal transition changes how well training works. Perimenopause often brings cognitive complaints and measurable changes in the same domains that training targets. Estrogen also affects neural plasticity. Yet the central meta-analysis cannot answer whether training works better, worse, or differently before, during, or after menopause. It did not report subgroup analyses by menopausal stage or sex, and 12 of its 15 primary studies used age rather than confirmed hormonal status to characterize participants.

That distinction matters. Biology gives researchers a sensible hypothesis. It does not give readers permission to call perimenopause a proven critical window for cognitive training.

What the midlife trials actually found

The Chen Zhu et al. meta-analysis pooled 19 randomized trials of healthy midlife adults. The studies covered six approaches: game-based training, general cognitive training, speed-of-processing exercises, working-memory training, strategy-based programs, and cognitive remediation. Across this mixed group of interventions, executive function improved by an SMD of 0.48. The review also found statistically significant improvements in verbal memory and working memory.

An SMD is a standardized difference between intervention and comparison groups, which lets researchers combine tests that use different scoring systems. An SMD of 0.48 sits between a small and moderate effect by common conventions. It does not tell us how much easier a specific participant found managing a calendar, resisting distraction at work, or remembering a name at dinner. The review also does not establish far transfer: whether practice gains reliably become better everyday functioning on untrained tasks.

Training protocols varied in format, frequency, length, and outcome measures. Five studies included follow-up assessments, but the pooled result does not settle how long gains last or which modality works best for a particular person. The fair conclusion is narrower than many brain-game advertisements: structured practice can improve measured cognitive domains in healthy midlife adults; the best program and the real-world payoff remain less certain.

Why perimenopause is a plausible target

Perimenopause is not cognitively identical for every woman, but it can be a period of change. In the SWAN cohort data discussed by Józwiak et al., subjective memory complaints rose from 31% before menopause to 44% in early perimenopause, then measured 41% in both late perimenopause and postmenopause. The largest step occurred at early perimenopause.

Observational work by Weber et al. also reported declines in attention, working memory, and verbal memory during perimenopause, with substantial variation among participants and correlations with hormonal measures. Those domains overlap with the outcomes that improved in the midlife training meta-analysis. This convergence makes the timing hypothesis reasonable: training may be especially useful when these abilities become more vulnerable.

But reasonable is not confirmed. The observational study did not test cognitive training, and the training review did not stratify results by a verified menopausal stage. We therefore have evidence for a midlife intervention and evidence for a perimenopausal vulnerability window, not evidence that the window changes the intervention effect.

Estrogen offers a mechanism, not a prescription

There is a biological case for studying hormonal status. Kling et al. describe estradiol-related changes in limbic dendritic spines and synapses and report that pituitary-ovarian hormone fluctuations relate to cognition in recently menopausal women. These findings support the idea that changing hormone levels could influence the conditions under which the brain learns.

They do not show that estrogen therapy enhances cognitive training. The interaction has not been tested in the available trials. Observational data from the IGNITE study linked lifetime estrogen exposure with domain-specific cognitive performance and associated surgical menopause with poorer cognitive-aging trajectories, but hormone-therapy findings were mixed. Association is not proof that restoring estrogen improves cognition, much less that it magnifies a training response.

The caution has direct trial support. The KEEPS-Cog substudy, summarized in James et al., found no significant cognitive effect of menopausal hormone therapy in recently postmenopausal women. A large Canadian cohort study by Puri et al. likewise found inconclusive associations among estradiol-based hormone therapy, age at menopause, and domain-specific cognitive performance. Hormone therapy may be appropriate for some menopausal symptoms after an individualized clinical discussion, but cognition is not a sound reason to assume it will boost training.

Build a broader program, but keep the evidence labels on

Several adjacent interventions have evidence worth considering, although they answer different questions in different populations. A six-month randomized trial of 140 postmenopausal women aged 50 to 64 tested 10 g daily of 99% cocoa chocolate against no intervention. In the Garcia-Yu et al. trial, Trail Making Test B time improved by 12.08 seconds versus control (95% CI, −23.99 to −0.18; p=0.047), after adjustment for specified factors. That is a statistically significant result on one executive-function measure, not proof that cocoa prevents cognitive decline.

Exercise is a sensible companion to mental practice, but the direct evidence is mostly older than the menopausal transition. In the 24-week AGUEDA randomized trial, 90 cognitively normal adults with a mean age of 71.8 were assigned to resistance exercise or control. The exercise group improved from baseline in overall executive function (SMD 0.39; 95% CI, 0.14 to 0.65), but the between-group difference in overall executive function was not significant (SMD 0.13; p=0.37). Attentional and inhibitory control did improve versus control (SMD 0.43; p<0.001). The AGUEDA report supports resistance training as a health practice with a potentially useful cognitive signal; it does not establish a broad executive-function benefit in midlife women.

A review by Titus et al. found that exercise trials in older adults produced mixed changes in BDNF and other neurotrophic or inflammatory markers across modalities. Such biomarkers may help explain exercise-related cognitive effects, but they are not proof of the pathway in any individual, and older-adult results cannot simply be assigned to perimenopause.

Mindfulness may also fit when anxiety, depression, sleep disruption, or stress worsen cognitive performance. In a meta-analysis of 10 randomized trials in older adults with mild cognitive impairment, Leow et al. reported improvements in attention, memory, global cognition, anxiety, and depression, plus reported neuroplastic changes. This is not a midlife or menopausal sample, so it is supporting evidence rather than a direct prescription. Psychological distress deserves attention in its own right: Ouyang et al. found that it impaired cognitive function in postmenopausal women. Future training studies need to measure changing distress, or they risk confusing symptom relief with training-specific effects.

What to do with the evidence now

Start structured cognitive training if you enjoy it and can sustain it. Choose programs that challenge executive function and working memory, the domains with both midlife trial evidence and perimenopausal relevance. Pair it with resistance and aerobic exercise for their established general health benefits and plausible, but incompletely tested, cognitive complementarity. Treat sleep, mood, metabolic health, and menopause symptoms as part of the same clinical picture rather than separate browser tabs.

Do not wait for a hormone-test result to begin, and do not treat hormone therapy as a cognitive-training enhancer. The evidence supports training in midlife. It supports studying menopause as a modifier. It has not yet shown that menopause changes the response.